Search results
-
Blog
Case Study: How We Helped a Sponsor Go From Safety Assessment to Proof-Of-Concept in 22 Months
See how Altasciences’ Acceleration Platform helped advance an incretin-based therapy to POC in ~22 months through integrated drug development.
-
Blog
Shaping the Future of Microsampling at Altasciences by Jeff Plomley
Jeff Plomley discusses how patient-centric blood microsampling can enable at-home, minimally invasive sample collection, and improve accessibility and clinical trial efficiency.
-
-
Blog
First-in-Human-Enabling Toxicology Programs: Common Misconceptions by Grace M. Furman
Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.
-
Blog
First-Timer Perspectives on Attending the AALAS National Meeting, by Brandon Ossont and Jennifer Lakritz
Brandon Ossont and Jennifer Lakritz share their first AALAS experiences, exploring scientific insights, networking, and professional growth in lab animal science.
-
Blog
Reflections on the ACT Annual Meeting: Where Science Meets Connection
Julie Forget reflects on the ACT Annual Meeting, highlighting cutting-edge toxicology research, gene therapy trends, and the strong sense of scientific community.